Stocks TelegraphStocks Telegraph
Stock Ideas

FLNA Financial Statements and Analysis

NASDAQ : FLNA

Filana Therapeutics

$0.99
-0.0197-1.95%
Open: 9:52 AM

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateMar 31, 2026
reported currencyUSD
calendar year2026
periodQ1
revenue0
cost of revenue243.00K
gross profit-243.00K
gross profit ratio0
research and development expenses4.544M
general and administrative expenses0
selling and marketing expenses0
selling general and administrative expenses6.381M
other expenses0
operating expenses10.925M
cost and expenses11.168M
interest income789.00K
interest expense0
depreciation and amortization243.00K
ebitda-10.088M
ebitda ratio0
operating income-11.168M
operating income ratio0
total other income expenses net837.00K
income before tax-10.331M
income before tax ratio0
income tax expense0
net income-10.331M
net income ratio0
eps-0.21
eps diluted-0.21
weighted average shs out48.308M
weighted average shs out dil48.308M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateMar 31, 2026
reported currencyUSD
calendar year2026
periodQ1
cash and cash equivalents86.573M
short term investments0
cash and short term investments86.573M
net receivables117.00K
inventory0
other current assets1.274M
total current assets87.964M
property plant equipment net20.403M
goodwill0
intangible assets0
goodwill and intangible assets0
long term investments0
tax assets0
other non current assets0
total non current assets20.403M
other assets0
total assets108.367M
account payables39.189M
short term debt0
tax payables0
deferred revenue0
other current liabilities926.00K
total current liabilities40.115M
long term debt0
deferred revenue non current0
deferred tax liabilities non current0
other non current liabilities110.999K
total non current liabilities110.999K
other liabilities0
capital lease obligations0
total liabilities40.226M
preferred stock0
common stock48.00K
retained earnings-506.415M
accumulated other comprehensive income loss0
other total stockholders equity574.508M
total stockholders equity68.141M
total equity68.141M
total liabilities and stockholders equity108.367M
minority interest0
total investments0
total debt0
net debt-86.573M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date
Graph

Frequently Asked Questions

How did Filana Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, FLNA generated $0.00 in revenue last quarter, while its costs came in at $243.00K.
Last quarter, how much Gross Profit did Filana Therapeutics, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Filana Therapeutics, Inc. reported a -$243.00K Gross Profit for the quarter ended Mar 31, 2026.
Have FLNA's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. FLNA incurred $10.93M worth of Operating Expenses, while it generated -$11.17M worth of Operating Income.
How much Net Income has FLNA posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Filana Therapeutics, Inc., the company generated -$10.33M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Filana Therapeutics, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Filana Therapeutics, Inc. as of the end of the last quarter was $86.57M.
What are FLNA's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, FLNA had Total Net Receivables of $117.00K.
In terms of Total Assets and Current Assets, where did Filana Therapeutics, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of FLNA were $87.96M, while the Total Assets stand at $108.37M.
As of the last quarter, how much Total Debt did Filana Therapeutics, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of FLNA's debt was $0.00 at the end of the last quarter.
What were FLNA's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, FLNA reported total liabilities of $40.23M.
How much did FLNA's Working Capital change over the last quarter?
Working Capital Change for FLNA was - over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
FLNA generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. FLNA generated - of Cash from Operating Activities during its recently reported quarter.
What was FLNA's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. FLNA reported a - Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph